-
EP3909590
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3909590
| EP3909590 - CELLULAR IMMUNOTHERAPY COMBINATION [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 22.09.2023 Database last updated on 03.09.2024 | |
| Former | Request for examination was made Status updated on 15.10.2021 | ||
| Former | The international publication has been made Status updated on 18.07.2020 | Most recent event Tooltip | 22.09.2023 | Application deemed to be withdrawn | published on 25.10.2023 [2023/43] | Applicant(s) | For all designated states CRAGE medical Co., Limited RM12, 20/F, Ho King Comm CTR 2-16 FaYuen ST Mongkok Kowloon Hong Kong / CN | [2022/16] |
| Former [2022/08] | For all designated states CAFA THERAPEUTICS LIMITED 2/3 Exchange Place, IFSC Dublin D01 AE27 / IE | ||
| Former [2021/46] | For all designated states Carsgen Therapeutics Co., Ltd. Building B Yindu Road 388 Xuhui District Shanghai 200231 / CN | ||
| For all designated states Shanghai Cancer Institute No. 25/Ln 2200 Xietu Road. Xuhui District Shanghai 200032 / CN | Inventor(s) | 01 /
LI, Zonghai Building B, No. 388 Yindu Road, Xuhui District Shanghai 200231 / CN | 02 /
WU, Xiuqi No. 25/Ln 2200 Xietu Road, Xuhui District Shanghai 200032 / CN | [N/P] |
| Former [2021/46] | 01 /
LI, Zonghai Shanghai 200231 / CN | ||
| 02 /
WU, Xiuqi Shanghai 200032 / CN | Representative(s) | Lavoix Bayerstraße 83 80335 München / DE | [2021/46] | Application number, filing date | 20738673.1 | 07.01.2020 | [2021/46] | WO2020CN70717 | Priority number, date | CN20191012164 | 07.01.2019 Original published format: CN201910012164 | [2021/46] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020143631 | Date: | 16.07.2020 | Language: | ZH | [2020/29] | Type: | A1 Application with search report | No.: | EP3909590 | Date: | 17.11.2021 | Language: | EN | [2021/46] | Search report(s) | International search report - published on: | CN | 16.07.2020 | (Supplementary) European search report - dispatched on: | EP | 13.10.2022 | Classification | IPC: | A61K35/17, A61K9/00, A61K31/7068, A61K35/15, A61K35/28, A61K39/00, A61K35/00, C07K14/725, C07K16/28, A61P35/00 | [2022/46] | CPC: |
A61K35/28 (EP);
A61K35/17 (KR,US);
A61K31/7068 (EP,KR,US);
A61K38/1774 (US);
A61K39/0011 (KR);
A61K39/4611 (EP);
A61K39/4631 (EP);
A61K39/464402 (EP,KR);
A61P35/00 (EP,US);
A61P35/04 (KR);
C07K14/7051 (EP);
C07K16/28 (EP);
A61K2039/5156 (KR);
A61K2039/5158 (KR);
A61K2121/00 (KR);
A61K2239/31 (EP);
A61K2239/38 (EP);
A61K2239/54 (EP);
A61K2300/00 (KR);
A61K9/0019 (EP);
C07K2317/622 (EP);
| C-Set: |
A61K31/7068, A61K2300/00 (EP)
|
| Former IPC [2021/46] | A61K35/17 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/46] | Title | German: | ZELLULÄRE IMMUNTHERAPIEKOMBINATION | [2021/46] | English: | CELLULAR IMMUNOTHERAPY COMBINATION | [2021/46] | French: | ASSOCIATION POUR IMMUNOTHÉRAPIE CELLULAIRE | [2021/46] | Entry into regional phase | 06.08.2021 | Translation filed | 06.08.2021 | National basic fee paid | 06.08.2021 | Search fee paid | 06.08.2021 | Designation fee(s) paid | 06.08.2021 | Examination fee paid | Examination procedure | 06.08.2021 | Amendment by applicant (claims and/or description) | 06.08.2021 | Examination requested [2021/46] | 13.05.2023 | Application deemed to be withdrawn, date of legal effect [2023/43] | 07.06.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2023/43] | Fees paid | Renewal fee | 06.08.2021 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 31.01.2023 | 04 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [YD]CN107058354 (CARSGEN BIOPHARMACEUTICAL (SHANGHAI) CO LTD); | International search | [A]CN107960056 (BIONTECH CELL & GENE THERAPIES GMBH, et al); | [Y]CN108853144 (CARSGEN THERAPEUTICS SHANGHAI CO LTD, et al); | by applicant | US4683195 | CN104140974 | WO2015172339 | CN105194661 | CN105315375 | CN105331585 | CN105713881 | CN106146666 | CN106397593 | CN106467573 | CN106519037 | CN106554414 | CN107058354 | WO2017186121 | CN107460201 | WO2018006882 | WO2018018958 |